(Q34521106)

English

A phase II dose ranging, double-blind, placebo-controlled study of alicaforsen enema in subjects with acute exacerbation of mild to moderate left-sided ulcerative colitis

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

2 August 2017

A phase II dose ranging, double-blind, placebo-controlled study of alicaforsen enema in subjects with acute exacerbation of mild to moderate left-sided ulcerative colitis (English)

1 reference

Europe PubMed Central

2 August 2017

1 reference

based on heuristic

inferred from title

author name string

van Deventer SJ

1

1 reference

Europe PubMed Central

2 August 2017

Wedel MK

2

1 reference

Europe PubMed Central

2 August 2017

Baker BF

3

1 reference

Europe PubMed Central

2 August 2017

Xia S

4

1 reference

Europe PubMed Central

2 August 2017

Chuang E

5

1 reference

Europe PubMed Central

2 August 2017

Miner PB Jr

6

1 reference

Europe PubMed Central

2 August 2017

language of work or name

0 references

publication date

1 May 2006

1 reference

Europe PubMed Central

2 August 2017

Alimentary Pharmacology & Therapeutics

1 reference

Europe PubMed Central

2 August 2017

23

1 reference

Europe PubMed Central

2 August 2017

1415-1425

1 reference

Europe PubMed Central

2 August 2017

10

1 reference

Europe PubMed Central

2 August 2017

Cotransfection of ICAM-1 and HLA-DR reconstitutes human antigen-presenting cell function in mouse L cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02910.X

21 January 2018

ICAM-1 (CD54): a counter-receptor for Mac-1 (CD11b/CD18)

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02910.X

21 January 2018

Changed colonic profile of P-selectin, platelet-endothelial cell adhesion molecule-1 (PECAM-1), intercellular adhesion molecule-1 (ICAM-1), ICAM-2, and ICAM-3 in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02910.X

21 January 2018

Subcellular localization of intercellular adhesion molecule-1 in colonic mucosa in ulcerative colitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02910.X

21 January 2018

Progress in antisense technology.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02910.X

21 January 2018

Determination of the role of the human RNase H1 in the pharmacology of DNA-like antisense drugs

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02910.X

21 January 2018

A placebo-controlled trial of ICAM-1 antisense oligonucleotide in the treatment of Crohn's disease.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02910.X

21 January 2018

A randomised, controlled, double blind, escalating dose study of alicaforsen enema in active ulcerative colitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02910.X

21 January 2018

An enema formulation of alicaforsen, an antisense inhibitor of intercellular adhesion molecule-1, in the treatment of chronic, unremitting pouchitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02910.X

21 January 2018

Distribution of mesalamine enemas in patients with active distal ulcerative colitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02910.X

21 January 2018

Identifiers

10.1111/J.1365-2036.2006.02910.X

1 reference

Europe PubMed Central

2 August 2017

1 reference

Europe PubMed Central

2 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34521106&oldid=1580121685"